Assenagon Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,119
Closed -$708K 1475
2023
Q3
$708K Sell
6,119
-1,193
-16% -$138K ﹤0.01% 1098
2023
Q2
$752K Buy
7,312
+64
+0.9% +$6.58K ﹤0.01% 998
2023
Q1
$791K Sell
7,248
-190,475
-96% -$20.8M ﹤0.01% 1073
2022
Q4
$22.5M Sell
197,723
-10,481
-5% -$1.19M 0.08% 207
2022
Q3
$12.9M Sell
208,204
-55,309
-21% -$3.42M 0.05% 276
2022
Q2
$21M Sell
263,513
-859,737
-77% -$68.6M 0.08% 202
2022
Q1
$118M Buy
1,123,250
+1,013,364
+922% +$107M 0.33% 46
2021
Q4
$11.8M Sell
109,886
-323,475
-75% -$34.9M 0.03% 263
2021
Q3
$47.5M Buy
433,361
+364,321
+528% +$39.9M 0.15% 97
2021
Q2
$6.47M Buy
+69,040
New +$6.47M 0.02% 397
2020
Q3
Sell
-54,899
Closed -$3.05M 1408
2020
Q2
$3.05M Buy
+54,899
New +$3.05M 0.02% 438
2020
Q1
Sell
-65,830
Closed -$2.38M 1025
2019
Q4
$2.38M Buy
+65,830
New +$2.38M 0.02% 358